Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant

Human Immunology

Volumn 70, Issue 8, 2009, Pages 580-583

  Aubert, Vincent ^a   Venetz, Jean Pierre ^a   Pantaleo, Giuseppe ^a   Pascual, Manuel ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Antibody mediated rejection; DSA; HLA antibodies; Luminex; Solid phase assay

Indexed keywords

BASILIXIMAB; CYCLOSPORIN; HLA ANTIBODY; HLA ANTIGEN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN DETECTION; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; BOLUS INJECTION; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; DONOR; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG MEGADOSE; FEMALE; GRAFT SURVIVAL; HLA MATCHING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; KIDNEY ALLOGRAFT; KIDNEY DISEASE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOLID PHASE ASSAY; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; ANTIBODY FORMATION; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; HLA ANTIGENS; HUMANS; IMMUNOSORBENT TECHNIQUES; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; MICROSPHERES; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANTATION IMMUNOLOGY;

EID: 68049142997     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.04.011     Document Type: Article

References (20)

1. Terasaki P.I. Humoral theory of transplantation. Am J Transplant 3 (2003) 665-673
2. Cai J., and Terasaki P.I. Humoral theory of transplantation-mechanism, prevention, and treatment. Hum Immunol 66 (2005) 334-342
3. Terasaki P.I., and Cai J. Humoral theory of transplantation: Further evidence. Curr Opin Immunol 17 (2005) 541-545
4. Akalin E., and Pascual M. Sensitization after Kidney Transplantation. Clin J Am Soc Nephrol 1 (2006) 433-440
5. Mao Q., Terasaki P.I., Cai J., Briley K., Catrou P., Haisch C., et al. Extremely high association between appearance of HLA antibodies and failure of kidney grafts in a five-year longitudinal study. Am J Transplant 7 (2007) 864-871
6. Lefaucheur C., Superbielle-Boissel C., Hill G.S., Nochy D., Andrade J., Antoine C., et al. Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Am J Transplant 8 (2008) 324-331
7. Gupta A., Iveson V., Varagunam M., Bodger S., Sinnott P., and Thuraisingham R.C. Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: Are they relevant?. Transplantation 85 (2008) 1200-1204
8. van den Berg-Loonen E.M., Billen E.V., Voorter C.E., van Heurn L.W., Claas F.H., van Hoof J.P., et al. Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients. Transplantation 85 (2008) 1086-1090
9. Patel A.M., Pancoska C., Mulgaonkar S., and Wenig F.L. Renal transplantation in patients with pretransplantation donor-specific antibodies and negative flow cytometry crossmatches. Am J Transplant 7 (2007) 2371-2377
10. Manuel O., Venetz J.P., Fellay J., Wasserfallen J.B., Sturzenegger N., Fontana M., et al. Efficacy and safety of universal valganciclovir prophylaxis combined with a tacrolimus/mycophenolate-based regimen in kidney transplantation. Swiss Med Weekly 137 (2007) 669-676
11. Gebel H.M., Bray R.A., and Nickerson P. Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: Contraindication vs. risk. Am J Transplant 3 (2003) 1488-1500
12. Billen E.V.A., Christiaans M.H.L., Lee J., and van den Berg-Loonen E.M. Donor-directed HLA antibodies before and after transplantectomy detected by the Luminex single antigen assay. Transplantation 87 (2009) 563-569
13. Higgins R., Hathaway M., Lowe D., Lam F., Kashi H., Tan L.C., et al. Blood levels of donor-specific human leukocyte antigen antibodies after renal transplantation: Resolution of rejection in the presence of circulating donor-specific antibody. Transplantation 84 (2007) 876-884
14. Billen E.V.A., Voorter C.E.M., Christiaans M.H.L., and van den Berg-Loonen E. Luminex donor-specific crossmatches. Tissue Antigens 71 (2008) 507-513
15. Gibney E.M., Cagle L.R., Freed B., Warnell S.E., Chan L., and Wiseman A.C. Detection of donor-specific antibodies using HLA-coated microspheres: Another tool for kidney transplant risk stratification. Nephrol Dial Transplant 21 (2006) 2625-2629
16. Pollinger H.S., Stegall M.D., Gloor J.M., Moore S.B., Degoey S.R., Ploeger N.A., et al. Kidney transplantation in patients with antibodies against donor HLA class II. Am J Transplant 7 (2007) 857-863
17. Süsal C., and Opelz G. Good kidney transplant outcome in recipients with presensitization against HLA class II but not HLA class I. Hum Immunol 65 (2004) 810-816
18. Akalin E., Dinavahi R., Friedlander R., Ames S., de Boccardo G., Sehgal V., et al. Addition of plasmapheresis decreases the incidence of acute antibody-mediated rejection in sensitized patients with strong donor-specific antibodies. Clin J Am Soc Nephrol 3 (2008) 1160-1167
19. Mizutani K., Terasaki P., Hamdani E., Esquenazi V., Rosen A., Miller J., et al. The importance of anti-HLA-specific antibody strength in monitoring kidney transplant patients. Am J Transplant 7 (2007) 1027-1031
20. Mai M.L., Ahsan N., Wadei H.M., Genco P.V., Geiger X.J., Willingham D.L., et al. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin. Transplantation 87 (2009) 227-232